نتائج البحث

METTL14 regulates CD8 + T-cell activation and immune responses to anti-PD-1 therapy in lung cancer.

• Authors : Sun C; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China.; Wang J

Subjects: CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/immunology ; CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/CD8-Positive T-Lymphocytes*/metabolism ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/pharmacology

• Source: World journal of surgical oncology [World J Surg Oncol] 2024 May 10; Vol. 22 (1), pp. 128. Date of Electronic Publication: 2024 May 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.

• Authors : Pei F; Department of Hepatobiliary Pancreatic Surgery, Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, No. 141 Tianjin Road, Huangshi, 435200, Hubei, China.; Tao Z

Subjects: Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/drug therapy ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/pathology ; Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/mortality

• Source: World journal of surgical oncology [World J Surg Oncol] 2024 Apr 25; Vol. 22 (1), pp. 110. Date of Electronic Publication: 2024 Apr 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

Neoadjuvant PD-1/PD-L1 combined with CTLA-4 inhibitors for solid malignancies: a systematic review and meta-analysis.

• Authors : Huang S; Department of Stomatology, Shapingba Hospital affiliated to Chongqing University, No.44, Xiaolongkan New Street, Chongqing, Shapingba District, 400030, China.; Zheng G

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Humans

• Source: World journal of surgical oncology [World J Surg Oncol] 2023 Nov 06; Vol. 21 (1), pp. 349. Date of Electronic Publication: 2023 Nov 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

Successful management of in-transit cutaneous squamous cell carcinoma with anti-PD-1 immunotherapy.

• Authors : Furkert C; North Shore Hospital, Auckland, New Zealand. .; Martin R

Subjects: Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/drug therapy ; Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/Carcinoma, Squamous Cell*/surgery ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/drug therapy

• Source: World journal of surgical oncology [World J Surg Oncol] 2023 Sep 15; Vol. 21 (1), pp. 291. Date of Electronic Publication: 2023 Sep 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion.

• Authors : Zhang Y; Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, P.R. of China.; Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Nanchang, 330006, P.R. of China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/mortality

• Source: World journal of surgical oncology [World J Surg Oncol] 2024 May 06; Vol. 22 (1), pp. 122. Date of Electronic Publication: 2024 May 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis.

• Authors : Cui, Qian^1,2,3 (AUTHOR); Li, Wentao^1,2 (AUTHOR); Wang, Dong^1,2,3 (AUTHOR)

• Source: World Journal of Surgical Oncology. 10/11/2023, Vol. 21 Issue 1, p1-16. 16p.

تفاصيل العنوان

Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis.

• Authors : Ma Y; Shijingshan Teaching Hospital of Capital Medical University, Beijing Shijingshan Hospital, #24 Shi Jing Shan Road, Beijing, Shijingshan District, 100040, China.; Department of Oncology, Beijing Friendship Hospital, Capital Medical University, #95 Yong An Road, Beijing, 100050, Xicheng District, China.

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; Eosinophils

• Source: World journal of surgical oncology [World J Surg Oncol] 2022 Jul 28; Vol. 20 (1), pp. 242. Date of Electronic Publication: 2022 Jul 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

TET1 mutations as a predictive biomarker for immune checkpoint inhibitors in colon adenocarcinoma.

• Authors : Qiu T; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China.; Wang X

Subjects: Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/drug therapy ; Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/genetics ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/drug therapy

• Source: World journal of surgical oncology [World J Surg Oncol] 2022 Apr 08; Vol. 20 (1), pp. 115. Date of Electronic Publication: 2022 Apr 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

A new marker constructed from immune-related lncRNA pairs can be used to predict clinical treatment effects and prognosis: in-depth exploration of underlying mechanisms in HNSCC.

• Authors : Fan, Xin¹ (AUTHOR); Huang, Yuhan² (AUTHOR); Zhong, Yun³ (AUTHOR)

• Source: World Journal of Surgical Oncology. 8/17/2023, Vol. 21 Issue 1, p1-23. 23p.

تفاصيل العنوان

Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort study.

• Authors : Zheng, Fei¹ (AUTHOR); Meng, Qingju² (AUTHOR); Zhang, Lei³ (AUTHOR)

• Source: World Journal of Surgical Oncology. 7/8/2023, Vol. 21 Issue 1, p1-11. 11p.

تفاصيل العنوان